The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings

被引：23

作者：

Bertagnolio, Silvia ^{[1
]}

Perno, Carlo Federico ^{[2
]}

Vella, Stefano ^{[3
]}

Pillay, Deenan ^{[4
]}

机构：

[1] WHO, HIV Dept, CH-1211 Geneva, Switzerland

[2] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy

[3] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy

[4] UCL, Res Dept Infect, London WC1E 6BT, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2013年 / 207卷

基金：

英国医学研究理事会;

关键词：

acquired and transmitted HIV drug resistance; antiretroviral therapy; HIV; low- and middle-income countries; resource-limited settings;

D O I：

10.1093/infdis/jit121

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S45 / S48

页数：4

共 6 条

[1]

[Anonymous], 2012, HIV drug resistance report

[2]

[Anonymous], 2020, HIGH POSS COST COVID

[3]

Bennett DE, 2008, ANTIVIR THER, V13, P1

[4] The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings [J].

Gilks, Charles F. ;

Crowley, Siobhan ;

Ekpini, Rene ;

Gove, Sandy ;

Perriens, Jos ;

Souteyrand, Yves ;

Sutherland, Don ;

Vitoria, Marco ;

Guerma, Teguest ;

De Cock, Kevin .

LANCET, 2006, 368 (9534) :505-510

[5]

WHO, 2010, ANT THER HIV INF AD

[6]

WHO, 2011, UN ACC SCAL PRIOR HI

← 1 →